Toiv Avi, Harris Kevin B, Khan Muhammad Zarrar, Theisen Brian K, Varma Adarsh, Fain Christopher, Kaur Nirmal
Department of Internal Medicine, Henry Ford Hospital, Detroit, MI.
Division of Gastroenterology, Henry Ford Hospital, Detroit, MI.
ACG Case Rep J. 2024 Nov 20;11(11):e01554. doi: 10.14309/crj.0000000000001554. eCollection 2024 Nov.
Post-transplant lymphoproliferative disorders (PTLD) are complications that arise from post-transplantation immunosuppressive therapy. Although Epstein-Barr virus (EBV) viremia is often seen in PTLD, it is not a definitive feature for diagnosis. We report a rare case of recurrent PTLD in a 26-year-old heart transplant recipient on high-dose tacrolimus who presented with emesis, fatigue, and bloody diarrhea. Although substantial EBV viremia was seen in the first PTLD episode, the current episode was a gastrointestinal manifestation with barely detectable circulating EBV. The patient's history of gastrointestinal disease delayed definitive diagnosis, which was later established through endoscopy and biopsy sample analysis.
移植后淋巴组织增生性疾病(PTLD)是移植后免疫抑制治疗引发的并发症。虽然在PTLD中常可见到爱泼斯坦-巴尔病毒(EBV)血症,但它并非诊断的决定性特征。我们报告了一例罕见的复发性PTLD病例,患者为一名26岁接受心脏移植的受者,正在接受大剂量他克莫司治疗,出现呕吐、疲劳和血性腹泻症状。虽然在首次PTLD发作时可见大量EBV血症,但此次发作表现为胃肠道症状,循环中的EBV几乎检测不到。该患者的胃肠道疾病史延误了明确诊断,最终通过内镜检查和活检样本分析得以确诊。